rs34220980

Variant summary

Our verdict is Pathogenic. The variant received 20 ACMG points: 20P and 0B. PVS1PS1_ModeratePM2PP5_Very_Strong

The NM_000558.5(HBA1):​c.1A>G​(p.Met1?) variant causes a start lost change. The variant allele was found at a frequency of 0.0000263 in 152,232 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).

Frequency

Genomes: 𝑓 0.000026 ( 0 hom., cov: 29)
Exomes 𝑓: 0.0000096 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

HBA1
NM_000558.5 start_lost

Scores

8
7
1

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:2

Conservation

PhyloP100: 5.12

Publications

15 publications found
Variant links:
Genes affected
HBA1 (HGNC:4823): (hemoglobin subunit alpha 1) The human alpha globin gene cluster located on chromosome 16 spans about 30 kb and includes seven loci: 5'- zeta - pseudozeta - mu - pseudoalpha-1 - alpha-2 - alpha-1 - theta - 3'. The alpha-2 (HBA2) and alpha-1 (HBA1) coding sequences are identical. These genes differ slightly over the 5' untranslated regions and the introns, but they differ significantly over the 3' untranslated regions. Two alpha chains plus two beta chains constitute HbA, which in normal adult life comprises about 97% of the total hemoglobin; alpha chains combine with delta chains to constitute HbA-2, which with HbF (fetal hemoglobin) makes up the remaining 3% of adult hemoglobin. Alpha thalassemias result from deletions of each of the alpha genes as well as deletions of both HBA2 and HBA1; some nondeletion alpha thalassemias have also been reported. [provided by RefSeq, Jul 2008]
HBA1 Gene-Disease associations (from GenCC):
  • alpha thalassemia spectrum
    Inheritance: AR, SD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • erythrocytosis, familial, 7
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • hemoglobin M disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Hb Bart's hydrops fetalis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • hemoglobin H disease
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • methemoglobinemia, alpha type
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen
  • Heinz body anemia
    Inheritance: AR Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 20 ACMG points.

PVS1
Start lost variant, next in-frame start position is after 15 pathogenic variants. Next in-frame start position is after 33 codons. Genomic position: 176930. Lost 0.226 part of the original CDS.
PS1
Another start lost variant in NM_000558.5 (HBA1) was described as [Likely_pathogenic] in ClinVar
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 16-176717-A-G is Pathogenic according to our data. Variant chr16-176717-A-G is described in ClinVar as Pathogenic. ClinVar VariationId is 2428673.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HBA1NM_000558.5 linkc.1A>G p.Met1? start_lost Exon 1 of 3 ENST00000320868.9 NP_000549.1 P69905D1MGQ2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HBA1ENST00000320868.9 linkc.1A>G p.Met1? start_lost Exon 1 of 3 1 NM_000558.5 ENSP00000322421.5 P69905

Frequencies

GnomAD3 genomes
AF:
0.0000263
AC:
4
AN:
152232
Hom.:
0
Cov.:
29
show subpopulations
Gnomad AFR
AF:
0.0000724
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000172
AC:
4
AN:
232006
AF XY:
0.0000237
show subpopulations
Gnomad AFR exome
AF:
0.000225
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.00000963
AC:
14
AN:
1454214
Hom.:
0
Cov.:
31
AF XY:
0.00000968
AC XY:
7
AN XY:
722990
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.000121
AC:
4
AN:
33106
American (AMR)
AF:
0.00
AC:
0
AN:
43690
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25992
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39356
South Asian (SAS)
AF:
0.0000704
AC:
6
AN:
85252
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52532
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5368
European-Non Finnish (NFE)
AF:
0.00000361
AC:
4
AN:
1108852
Other (OTH)
AF:
0.00
AC:
0
AN:
60066
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.304
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000263
AC:
4
AN:
152232
Hom.:
0
Cov.:
29
AF XY:
0.0000269
AC XY:
2
AN XY:
74374
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.0000724
AC:
3
AN:
41436
American (AMR)
AF:
0.00
AC:
0
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5208
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4838
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68040
Other (OTH)
AF:
0.00
AC:
0
AN:
2092
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0.000356006), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.338
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
ExAC
AF:
0.0000166
AC:
2

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

alpha Thalassemia;C0700299:Heinz body anemia;C3161174:Hemoglobin H disease;C4693798:Methemoglobinemia, alpha type;C4693823:Erythrocytosis, familial, 7 Pathogenic:1
Feb 13, 2024
Fulgent Genetics, Fulgent Genetics
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Pathogenic:1
Apr 21, 2022
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The HBA1 c.1A>G; p.Met1? variant (rs34220980, HbVar ID: 1063), also known as alpha1 NcoI, is reported heterozygous in the literature in individuals with hypochromia and variable microcytosis (see Hbvar and references therein, Desogus 2015). Further, this variant has been observed in trans with double and single alpha globin gene deletions in individuals with Hb H disease and alpha thalassemia trait respectively (HbVar, Desogus 2015). This variant disrupts the translation initiation codon, resulting in reduced alpha globin protein. This variant is found in the African population with an allele frequency of 0.2% (4/22010 alleles) in the Genome Aggregation Database. Based on available information, this variant is considered to be pathogenic. References: Link to HbVar database: https://globin.bx.psu.edu/hbvar/menu.html Desogus MF et al. Investigating the alpha1(NcoI) mutation. Acta Haematol. 2015;133(2):145-7. PMID: 25247841. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.26
D
BayesDel_noAF
Pathogenic
0.42
CADD
Benign
23
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.55
D
Eigen
Uncertain
0.22
Eigen_PC
Uncertain
0.23
FATHMM_MKL
Uncertain
0.95
D
LIST_S2
Uncertain
0.90
D
M_CAP
Pathogenic
0.93
D
MetaRNN
Pathogenic
0.99
D
MetaSVM
Pathogenic
0.81
D
PhyloP100
5.1
PROVEAN
Uncertain
-2.4
N
REVEL
Pathogenic
0.88
Sift
Pathogenic
0.0
D
Sift4G
Pathogenic
0.0
D
Vest4
0.98
MutPred
1.0
Loss of MoRF binding (P = 0.0883);
MVP
1.0
ClinPred
0.93
D
GERP RS
4.5
PromoterAI
-0.26
Neutral
Varity_R
0.93
gMVP
0.69
Mutation Taster
=7/193
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs34220980; hg19: chr16-226716; API